QualityStocksNewsBreaks Archives - Page 1057 of 1522

WednesdayMar 25, 2020 11:19 am

QualityStocksNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTC: SHRMF) (FWB: 496) Appoints Ernst & Young 2018 Entrepreneur of the Year in Health Care to Special Advisory Committee

Champignon Brands (CSE: SHRM) (OTC: SHRMF) (FWB: 496), a health and wellness company specializing in the formulation of a suite of medicinal mushroom health products, as well as novel delivery platforms for the pharmaceutical and nutraceutical industries, today announced the appointment of Dr. Joseph Gabriele, a molecular pharmacologist specializing in signal transduction within the central nervous system, to its Special Advisory Committee. According to the update, Dr. Gabriele, PhD, specializes in the areas of molecular pharmacology, transdermal delivery and formulation chemistry with pharmaceutical, natural molecules and will champion the company’s development and commercialization of rapid onset treatments capable of improving…

WednesdayMar 25, 2020 10:14 am

QualityStocksNewsBreaks – Wonderfilm Media Corporation (TSX.V: WNDR) (OTCQB: WDRFF) Releases Corporate Update, to Reinstate Trading on TSX Venture Exchange

Wonderfilm Media Corporation (TSX.V: WNDR) (OTCQB: WDRFF) on Tuesday announced that its board of directors has appointed Stephen Brown as the president, chief executive officer and as a director of the company and Mark Groenewald as the chief financial officer of the company, effective immediately. In addition, the common shares in the capital of Wonderfilm Media Corporation will be reinstated to trading on the TSX Venture Exchange on March 26, 2020. “We're thrilled to have two individuals with Mr. Brown and Mr. Groenewald's knowledge and experience step into the role of President and Chief Executive Officer and Chief Financial Officer…

WednesdayMar 25, 2020 9:58 am

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) to Webcast Live at March 26 Life Sciences Investor Forum

Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP), a global innovator in drug delivery platforms, on Tuesday announced that its Chief Executive Officer, Chris Bunka, will present live at LifeSciencesInvestorForum.com on March 26. According to the update, Bunka’s presentation is scheduled to begin at 12:00 PM ET. The live, interactive online event invites investors to ask the company questions in real-time. It is suggested that interested parties pre-register and run the online system check to expedite participation and receive event updates. An archived webcast will be made available after the event for those unable to join live on the day of the…

WednesdayMar 25, 2020 9:22 am

QualityStocksNewsBreaks – Sigma Labs, Inc. (NASDAQ: SGLB) Reports Q4, Full Year 2019 Financial Results; Hosts Conference Call

Sigma Labs (NASDAQ: SGLB), a leading developer of quality assurance software for the commercial 3D printing industry, on Tuesday reported its financial and operational results for the fourth quarter and full year ended December 31, 2019. Among other highlights, the company reported that revenue for the full year of 2019 totaled $402,000, and that $133,000, or 33% was earned in the fourth quarter. This compares to total revenue of $388,000 for the full year of 2018, of which $56,000 was earned in the fourth quarter of 2018. Sigma Labs’ Executive Chairman Mark Ruport, CEO John Rice and CFO Frank Orzechowski…

TuesdayMar 24, 2020 2:51 pm

QualityStocksNewsBreaks – InsuraGuest Technologies Inc. (TSX.V: ISGI) Subsidiary Launches New Agency/Broker Program

InsuraGuest Technologies (TSX.V: ISGI), under its wholly owned U.S. subsidiary InsuraGuest Insurance Agency, LLC (the “Agency”), this morning announced the successful launch of its Agency/Broker Program. The program is designed to concentrate on agencies and brokers that write general liability polices specifically for hotels and vacation rental properties. InsuraGuest’s Insurtech platform is adept at integrating with roughly 71 different hotel and vacation rental property management systems, granting it access to millions of rooms worldwide. “We have already signed up a major broker in Salt Lake City, Utah, and, due to demand, we are expanding our marketing efforts to include agents/brokers…

TuesdayMar 24, 2020 1:23 pm

QualityStocksNewsBreaks – SinglePoint, Inc. (SING) Subsidiary Achieves Promising Results During First Week of Virtual Solar Sales

SinglePoint (OTCQB: SING) today announced that its Direct Solar America subsidiary has positioned the entire company for success as its first week of virtual sales demonstrated encouraging results. Per the release, SinglePoint has always intended on moving to an entirely online purchase system, and current conditions have acted as a catalyst to implement this vision now. In the first week, Direct Solar has closed multiple deals and is developing a pipeline of additional homeowners setting up new appointments. Direct Solar America is currently bringing on additional virtual agents. If you are interested in setting appointments or selling solar, call 844-830-1615.…

TuesdayMar 24, 2020 10:20 am

QualityStocksNewsBreaks – Genprex, Inc. (NASDAQ: GNPX) Announces Strategic Board Appointments of Three Biotechnology and Healthcare Industry Leaders

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, today announced the appointment of three new members to its Board of Directors. The new appointments, which include Brent Longnecker, CEO of Longnecker & Associates, Jose A. Moreno Toscano, CEO of LFB USA Inc, and William R. (“Will”) Wilson, Jr., chairman, president and CEO of Wilson Land & Cattle Co., are designed to strengthen Genprex as it executes on its key clinical programs, continues to build its pipeline, and evaluates future license or corporate partnership agreements. “We are honored to have Brent,…

TuesdayMar 24, 2020 10:06 am

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) to Participate in Life Sciences Investor Forum’s Virtual Conference

Life Sciences Investor Forum today announced the schedule for its inaugural event for both public and private companies, investors and worldwide industry professionals. The one-day event is kicking off on Thursday, March 26 with the first live webcast at 9:30 AM ET. Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP), a global innovator in drug delivery platforms, is scheduled to provide a presentation at 12:00 PM ET on March 26. Per the release, pre-registration is recommended for investors and it is encouraged that they run the online system check to expedite participation and receive event updates. There is no cost to view…

MondayMar 23, 2020 1:50 pm

QualityStocksNewsBreaks – Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) Commences Delivery of $3M to $5M of Rugged and In-Vehicle Push-to-Talk Devices

Siyata Mobile (TSX.V: SIM) (OTCQX: SYATF) today announced that it has commenced delivery on its large government tender for up to 15,000 push-to-talk devices, previously announced on December 02, 2019. According to the update, the majority of the order is anticipated to be delivered in Q1 and Q2 and the tender is valued between $3-million to $5-million, depending on the total units and mix between rugged handsets and in-vehicle devices. “Make no mistake, push-to-talk devices are mission critical solutions for public safety workers on the first line of defense; they are supported by dedicated cellular networks to improve communication, while…

MondayMar 23, 2020 1:25 pm

QualityStocksNewsBreaks – Genprex, Inc. (NASDAQ: GNPX) Expands Leadership Team with Appointment of Accomplished Life Science Executives

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, today announced the appointment of Catherine M. Vaczy as executive vice president and chief strategy officer and Michael T. Redman as executive vice president and chief operating officer. These appointments follow on the heels of Genprex’s Fast Track Designation for its lead drug candidate, its newly licensed gene therapy for diabetes, and over $26 million capital raise that will support funding of its clinical programs. “We are delighted to welcome Catherine and Michael to our executive leadership team. They join us at…

Site Search

Company Search

Category: QualityStocksNewsBreaks